Allele Capital Partners

Fort Lauderdale, Florida

Founded:2017

Firm Location:Fort Lauderdale, Florida • West Palm Beach, Florida • Boca Raton, Florida • New York City

Allele Capital Partners Team

Photo of Ankit Bhargava, Managing Director at Allele Capital Partners

Allele Capital Partners·Managing Director

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Fort Lauderdale (FL)

Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)

to see your intro paths to Ankit

Photo of Brian Debeer, Analyst at Allele Capital Partners

Allele Capital Partners·Analyst

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in West Palm Beach (FL)

Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)

to see your intro paths to Brian

Photo of Matt Hughes, Managing Director at Allele Capital Partners

Allele Capital Partners·Managing Director

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boca Raton (FL)

Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in BioTech (Series A), Investors in FinTech (Series B), Investors in BioTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)

to see your intro paths to Matt

Photo of Menachem Kranz, Managing Partner at Allele Capital Partners

Allele Capital Partners·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boca Raton (FL)

Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series B), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in FinTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)

to see your intro paths to Menachem

Photo of Tom Masterson, Managing Director at Allele Capital Partners

Allele Capital Partners·Managing Director

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Fort Lauderdale (FL)

Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)

to see your intro paths to Tom

Photo of Kumar Singh, Vice President at Allele Capital Partners

Allele Capital Partners·Vice President

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in New York City

Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Real Estate/PropTech (Series B), Investors in Therapeutics (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Therapeutics (Seed), Investors in Real Estate/PropTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Real Estate/PropTech (Series B), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Real Estate/PropTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists)

to see your intro paths to Kumar

Photo of Shawn Titcomb, Investor at Allele Capital Partners

Allele Capital Partners·Investor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Fort Lauderdale (FL)

Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)

to see your intro paths to Shawn